How GLP-1 treatment can affect menstrual cycles

Periods are not the headline GI side effect, and they still matter

Nausea and constipation dominate GLP-1 counseling. Menstrual changes still show up in clinics because body fat, insulin, thyroid status, and pregnancy risk all move when weight changes quickly. Labels focus on pregnancy prevention more than on spotting or cycle length, which is why this page exists.

This is educational information, not OB-GYN care. A missed period is a pregnancy question until testing says otherwise. Beema Health pages do not collect menstrual dates or pregnancy information.

Weight, energy availability, and ovulation

Adipose tissue and energy availability influence reproductive hormones. People who had irregular cycles related to obesity sometimes see more regular ovulation after weight reduction. People who drop intake too far, or who lose weight very rapidly, can also skip periods. Both directions are biologically plausible.

Office on Women's Health education notes that stress, extreme exercise, and weight change can alter cycles. GLP-1-related nausea that leads to very low intake can look like an energy-availability problem. That still needs a clinician if periods stop for months or become newly chaotic.

Oral contraceptives and delayed emptying

Zepbound prescribing information is explicit: delayed gastric emptying may reduce oral hormonal contraceptive effectiveness. The delay is largest after the first dose and lessens over time. The labeled approach is a non-oral contraceptive or a barrier method for 4 weeks after starting and for 4 weeks after each dose increase.

Wegovy labeling's reproductive section focuses on fetal harm and the 2-month washout before planned pregnancy rather than the same oral-contraceptive interaction paragraph. People on any GLP-1 who use pills should still confirm the plan with the prescribing clinician and the clinician who manages contraception. Do not assume "I have been on the pill for years" cancels labeled interaction language.

Pregnancy warnings and planning

Weight-management indications for products such as Wegovy and Zepbound exclude pregnancy. Animal data raise fetal-harm concerns. If pregnancy is recognized, labels instruct stopping the medicine and contacting a clinician. Semaglutide's long half-life is why Wegovy labeling includes a 2-month discontinuation window before planned conception.

Weight loss can increase fertility even when cycles were previously irregular. That is a safety issue, not a fertility-clinic promise. Anyone who can become pregnant needs a contraception plan that matches the GLP-1 they are prescribed.

PCOS research and its limits

Researchers have studied GLP-1 receptor agonists in PCOS because insulin resistance and weight affect androgens and ovulation. An open-label randomized trial of metformin plus semaglutide versus metformin reported higher rates of menstrual-cycle recovery at 16 weeks in the combination group. Open-label design, selected participants, and short follow-up limit how far that result can be generalized.

Beema Health does not present GLP-1 treatment as a PCOS cure or as a pregnancy program. If periods are the main health goal, that belongs in a visit with a clinician who can discuss evidence, teratogenicity, and alternatives.

When to seek care for bleeding or cycle changes

Seek emergency care for hemorrhage, pregnancy with bleeding, or severe pelvic pain with fever. Contact a clinician for periods that suddenly become very heavy, last much longer than usual, or stop for several months without a known reason. Postmenopausal bleeding is never "just the GLP-1."

Share the medication name and last dose with the clinician. Do not start or stop a GLP-1 to regulate a cycle without medical direction. Related articles cover acne, bloating, and stopping treatment if a pregnancy plan changes.

• Emergency: soaking a pad hourly, pregnancy bleeding, fainting, fever with severe pelvic pain.
• Prompt visit: new missed periods, very heavy clots, or a positive pregnancy test.
• Planning: ask about washout timing before conception and about non-oral contraception on tirzepatide.

Frequently asked questions

Sources

1. [1] Wegovy (semaglutide) injection Prescribing Information. Novo Nordisk. DailyMed.
2. [2] Zepbound (tirzepatide) injection Prescribing Information. Eli Lilly.
3. [3] Office on Women's Health. Menstrual cycle.
4. [4] NIDDK. Prescription Medications to Treat Overweight & Obesity.
5. [5] Chen H, Lei X, Yang Z, et al. Combined metformin and semaglutide in overweight/obese women with PCOS (open-label RCT). Reproductive Biology and Endocrinology. 2025.